Digital Medicine in Meditation

Scripps Translational Science Institute1 site in 1 country40 target enrollmentStarted: October 2013Last updated: March 13, 2014

Conditions

Trial Snapshot

Phase: Not Applicable
Status: Completed
Sponsor
Enrollment: 40
Locations: 1
Primary Endpoint: Blood Pressure

Study Overview Study Design Eligibility Criteria Outcomes Investigators Sites Records & Identifiers Similar Trials

Study Overview

Brief Summary

This study will investigate the acute response to meditation during a week-long meditation retreat at the Chopra Center as measured by the continuous, simultaneous monitoring of numerous biometric parameters in selected cohorts of experienced and novice meditators during periods of meditation and specific breathing techniques. Comparisons between cohorts as well as over time will allow for the identification of meditation and/or breathing-related changes.

Detailed Description

The biometric responses to meditation and breathing techniques will be compared between novice and experienced meditators, as well as initial versus final biometric responses in all participants stratified by cohort. Investigators hypothesize that novice meditators will experience a measurable change in response to mediation over the week-long retreat, whereas experienced meditators will demonstrate a more robust response than novice meditators on the first day of the retreat with less change over the retreat.

Study Design

Study Type: Observational
Observational Model: Cohort
Time Perspective: Prospective

Eligibility Criteria

Ages: 18 Years to — (Adult, Older Adult)
Sex: All
Accepts Healthy Volunteers: Yes

Inclusion Criteria

•Adult over age 18 who are already registered to participate in the week-long "Seduction of the Soul" retreat.
•Capable of providing informed consent

Exclusion Criteria

•Chronic requirement for daily use of chronotropically active medications including beta-blockers, non-dihydropyridine calcium channel blockers, clonidine or beta-agonist inhalers.
•Implantable pacemaker or cardioverter-defibrillator.
•Known allergy to adhesives.